Previous investigations of the prognostic value of cyclin E levels by using immunohistochemical techniques have produced conflicting results, for example, in breast cancer (Porter et al, 1997; Donnellan et al, 2001) and lung cancer (Anton et al, 2000; Muller-Tidow et al, 2001). This evidence concerns the gene CCNE1 and lung cancer.